Innoviva Specialty Therapeutics’ Antimicrobial Therapies, XACDURO®, ZEVTERA® and NUZOLVENCE® Designated Finalists for the 2026 Prix Galien USA Best Pharmaceutical Product Award
Business Wire•11/08/2026•16:05 ET
0
Whiz Insights
Get started
Create a free account to read the full story.